Gengxi Cai

Foshan, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

MRI-Based Deep Learning Guides Multi-Omics Discovery of NBPF4 as a Therapeutic Target for Breast Cancer Lymph Node Metastasis.

MRI-Based Deep Learning Guides Multi-Omics Discovery of NBPF4 as a Therapeutic Target for Breast Cancer Lymph Node Metastasis.

Journal: Research (Washington, D.C.)
Published: April 15, 2026

The GCN5L2-SIX1 complex drives glycolysis to promote progression of triple-negative breast cancer.

The GCN5L2-SIX1 complex drives glycolysis to promote progression of triple-negative breast cancer.

Journal: Cancer letters
Published: February 27, 2026

Interpretable MRI-Based Machine Learning Model for Noninvasive Prediction of Axillary Lymph Node Metastasis After Neoadjuvant Chemotherapy in Breast Cancer.

Interpretable MRI-Based Machine Learning Model for Noninvasive Prediction of Axillary Lymph Node Metastasis After Neoadjuvant Chemotherapy in Breast Cancer.

Journal: Academic radiology
Published: November 08, 2025

The RPS15-DDX21 complex drives prostate malignancy through transcriptional activation of SCD1.

The RPS15-DDX21 complex drives prostate malignancy through transcriptional activation of SCD1.

Journal: Oncogene
Published: November 06, 2025

Lymph Node Metastasis-Associated Spatiotemporal Mapping of the TFF3-Linked Niche in Breast Cancer: Integrating Radiogenomic Signatures with Immune-Ecosystem Remodeling.

Lymph Node Metastasis-Associated Spatiotemporal Mapping of the TFF3-Linked Niche in Breast Cancer: Integrating Radiogenomic Signatures with Immune-Ecosystem Remodeling.

Journal: Research (Washington, D.C.)
Published: August 27, 2025

WBP11 inhibits UFL1-mediated UFMylation of NONO to drive hepatocellular carcinoma progression.

WBP11 inhibits UFL1-mediated UFMylation of NONO to drive hepatocellular carcinoma progression.

Journal: Oncogene
Published: February 26, 2025

Resveratrol suppresses growth and VCAN expression in a Cancer-associated fibroblast-breast Cancer hybrid organoid.

Resveratrol suppresses growth and VCAN expression in a Cancer-associated fibroblast-breast Cancer hybrid organoid.

Journal: International immunopharmacology
Published: January 08, 2025

Ku70 targets BRD3-MYC/Cyclin D1 axis to drive hepatocellular carcinoma progression.

Ku70 targets BRD3-MYC/Cyclin D1 axis to drive hepatocellular carcinoma progression.

Journal: Experimental cell research
Published: September 27, 2024

METTL14-mediated m6A modification enhances USP22-ERα axis to drive breast cancer malignancy.

METTL14-mediated m6A modification enhances USP22-ERα axis to drive breast cancer malignancy.

Journal: Pharmacological research
Published: September 21, 2024

The Ku70-SIX1-GPT2 axis regulates alpha-ketoglutarate metabolism to drive progression of prostate cancer.

The Ku70-SIX1-GPT2 axis regulates alpha-ketoglutarate metabolism to drive progression of prostate cancer.

Journal: Oncogene
Published: July 23, 2024

Promoter profiles in plasma CfDNA exhibits a potential utility of predicting the efficacy of neoadjuvant chemotherapy in breast cancer patients.

Promoter profiles in plasma CfDNA exhibits a potential utility of predicting the efficacy of neoadjuvant chemotherapy in breast cancer patients.

Journal: Breast cancer research : BCR
Published: April 07, 2024

Short-term efficacy and safety of neoadjuvant pyrotinib plus taxanes for early HER2-positive breast cancer: a single-arm exploratory phase II trial.

Short-term efficacy and safety of neoadjuvant pyrotinib plus taxanes for early HER2-positive breast cancer: a single-arm exploratory phase II trial.

Journal: Gland surgery
Published: January 29, 2024
Showing 1-12 of 18

Last Updated: 09/26/2026